-
1
-
-
35448963479
-
Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions
-
Advani A, Kelly DJ, Advani SL, Cox AJ, Thai K, Zhang Y, White KE, Gow RM, Marshall SM, Steer BM, Marsden PA, Rakoczy PE, Gilbert RE. Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions. Proc Natl Acad Sci USA 104: 14448-14453, 2007.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 14448-14453
-
-
Advani, A.1
Kelly, D.J.2
Advani, S.L.3
Cox, A.J.4
Thai, K.5
Zhang, Y.6
White, K.E.7
Gow, R.M.8
Marshall, S.M.9
Steer, B.M.10
Marsden, P.A.11
Rakoczy, P.E.12
Gilbert, R.E.13
-
2
-
-
7044260750
-
Podocytederived vascular endothelial growth factor mediates the stimulation of alpha3(IV) collagen production by transforming growth factor-beta1 in mouse podocytes
-
Chen S, Kasama Y, Lee JS, Jim B, Marin M, Ziyadeh FN. Podocytederived vascular endothelial growth factor mediates the stimulation of alpha3(IV) collagen production by transforming growth factor-beta1 in mouse podocytes. Diabetes 53: 2939-2949, 2004.
-
(2004)
Diabetes
, vol.53
, pp. 2939-2949
-
-
Chen, S.1
Kasama, Y.2
Lee, J.S.3
Jim, B.4
Marin, M.5
Ziyadeh, F.N.6
-
3
-
-
31644437497
-
Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy
-
Cohen MP, Chen S, Ziyadeh FN, Shea E, Hud EA, Lautenslager GT, Shearman CW. Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy. Kidney Int 68: 1554-1561, 2005.
-
(2005)
Kidney Int
, vol.68
, pp. 1554-1561
-
-
Cohen, M.P.1
Chen, S.2
Ziyadeh, F.N.3
Shea, E.4
Hud, E.A.5
Lautenslager, G.T.6
Shearman, C.W.7
-
4
-
-
0032712434
-
Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes
-
Cooper ME, Vranes D, Youssef S, Stacker SA, Cox AJ, Rizkalla B, Casley DJ, Bach LA, Kelly DJ, Gilbert RE. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 48: 2229-2239, 1999.
-
(1999)
Diabetes
, vol.48
, pp. 2229-2239
-
-
Cooper, M.E.1
Vranes, D.2
Youssef, S.3
Stacker, S.A.4
Cox, A.J.5
Rizkalla, B.6
Casley, D.J.7
Bach, L.A.8
Kelly, D.J.9
Gilbert, R.E.10
-
5
-
-
0035034655
-
Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes
-
de Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 12: 993-1000, 2001.
-
(2001)
J Am Soc Nephrol
, vol.12
, pp. 993-1000
-
-
de Vriese, A.S.1
Tilton, R.G.2
Elger, M.3
Stephan, C.C.4
Kriz, W.5
Lameire, N.H.6
-
6
-
-
33645456580
-
Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival
-
Eremina V, Cui S, Gerber H, Ferrara N, Haigh J, Nagy A, Ema M, Rossant J, Jothy S, Miner JH, Quaggin SE. Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am Soc Nephrol 17: 724-735, 2006.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 724-735
-
-
Eremina, V.1
Cui, S.2
Gerber, H.3
Ferrara, N.4
Haigh, J.5
Nagy, A.6
Ema, M.7
Rossant, J.8
Jothy, S.9
Miner, J.H.10
Quaggin, S.E.11
-
7
-
-
40849130173
-
VEGF inhibition and renal thrombotic microangiopathy
-
Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358: 1129-1136, 2008.
-
(2008)
N Engl J Med
, vol.358
, pp. 1129-1136
-
-
Eremina, V.1
Jefferson, J.A.2
Kowalewska, J.3
Hochster, H.4
Haas, M.5
Weisstuch, J.6
Richardson, C.7
Kopp, J.B.8
Kabir, M.G.9
Backx, P.H.10
Gerber, H.P.11
Ferrara, N.12
Barisoni, L.13
Alpers, C.E.14
Quaggin, S.E.15
-
8
-
-
0037370325
-
Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases
-
Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, Gerber HP, Kikkawa Y, Miner JH, Quaggin SE. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111: 707-716, 2003.
-
(2003)
J Clin Invest
, vol.111
, pp. 707-716
-
-
Eremina, V.1
Sood, M.2
Haigh, J.3
Nagy, A.4
Lajoie, G.5
Ferrara, N.6
Gerber, H.P.7
Kikkawa, Y.8
Miner, J.H.9
Quaggin, S.E.10
-
9
-
-
0036789207
-
Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody
-
Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS, Schrijvers BF, Tilton RG, Rasch R. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 51: 3090-3094, 2002.
-
(2002)
Diabetes
, vol.51
, pp. 3090-3094
-
-
Flyvbjerg, A.1
Dagnaes-Hansen, F.2
De Vriese, A.S.3
Schrijvers, B.F.4
Tilton, R.G.5
Rasch, R.6
-
10
-
-
0036329383
-
Compensatory glomerular growth after unilateral nephrectomy is VEGF dependent
-
Flyvbjerg A, Schrijvers BF, De Vriese AS, Tilton RG, Rasch R. Compensatory glomerular growth after unilateral nephrectomy is VEGF dependent. Am J Physiol Endocrinol Metab 283: E362-E366, 2002.
-
(2002)
Am J Physiol Endocrinol Metab
, vol.283
-
-
Flyvbjerg, A.1
Schrijvers, B.F.2
De Vriese, A.S.3
Tilton, R.G.4
Rasch, R.5
-
11
-
-
0038623780
-
Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes
-
Foster RR, Hole R, Anderson K, Satchell SC, Coward RJ, Mathieson PW, Gillatt DA, Saleem MA, Bates DO, Harper SJ. Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. Am J Physiol Renal Physiol 284: F1263-F1273, 2003.
-
(2003)
Am J Physiol Renal Physiol
, vol.284
-
-
Foster, R.R.1
Hole, R.2
Anderson, K.3
Satchell, S.C.4
Coward, R.J.5
Mathieson, P.W.6
Gillatt, D.A.7
Saleem, M.A.8
Bates, D.O.9
Harper, S.J.10
-
12
-
-
11144287218
-
Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes
-
Foster RR, Saleem MA, Mathieson PW, Bates DO, Harper SJ. Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes. Am J Physiol Renal Physiol 288: F48-F57, 2005.
-
(2005)
Am J Physiol Renal Physiol
, vol.288
-
-
Foster, R.R.1
Saleem, M.A.2
Mathieson, P.W.3
Bates, D.O.4
Harper, S.J.5
-
13
-
-
33847615623
-
Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies
-
Gerber HP, Wu X, Yu L, Wiesmann C, Liang XH, Lee CV, Fuh G, Olsson C, Damico L, Xie D, Meng YG, Gutierrez J, Corpuz R, Li B, Hall L, Rangell L, Ferrando R, Lowman H, Peale F, Ferrara N. Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies. Proc Natl Acad Sci USA 104: 3478-3483, 2007.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 3478-3483
-
-
Gerber, H.P.1
Wu, X.2
Yu, L.3
Wiesmann, C.4
Liang, X.H.5
Lee, C.V.6
Fuh, G.7
Olsson, C.8
Damico, L.9
Xie, D.10
Meng, Y.G.11
Gutierrez, J.12
Corpuz, R.13
Li, B.14
Hall, L.15
Rangell, L.16
Ferrando, R.17
Lowman, H.18
Peale, F.19
Ferrara, N.20
more..
-
14
-
-
33745089314
-
Adeno-associated virus as a gene therapy vector: Vector development, production and clinical applications
-
Grieger JC, Samulski RJ. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications. Adv Biochem Eng Biotechnol 99: 119-145, 2005.
-
(2005)
Adv Biochem Eng Biotechnol
, vol.99
, pp. 119-145
-
-
Grieger, J.C.1
Samulski, R.J.2
-
15
-
-
0038235832
-
ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy
-
Gross ML, El-Shakmak A, Szabo A, Koch A, Kuhlmann A, Munter K, Ritz E, Amann K. ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy. Diabetologia 46: 856-868, 2003.
-
(2003)
Diabetologia
, vol.46
, pp. 856-868
-
-
Gross, M.L.1
El-Shakmak, A.2
Szabo, A.3
Koch, A.4
Kuhlmann, A.5
Munter, K.6
Ritz, E.7
Amann, K.8
-
16
-
-
29644434152
-
A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy
-
Guo M, Ricardo SD, Deane JA, Shi M, Cullen-McEwen L, Bertram JF. A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy. J Anat 207: 813-821, 2005.
-
(2005)
J Anat
, vol.207
, pp. 813-821
-
-
Guo, M.1
Ricardo, S.D.2
Deane, J.A.3
Shi, M.4
Cullen-McEwen, L.5
Bertram, J.F.6
-
17
-
-
85047697288
-
2-(8-Hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice
-
Ichinose K, Maeshima Y, Yamamoto Y, Kinomura M, Hirokoshi K, Kitayama H, Takazawa Y, Sugiyama H, Yamasaki Y, Agata N, Makino H. 2-(8-Hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice. Diabetes 55: 1232-1242, 2006.
-
(2006)
Diabetes
, vol.55
, pp. 1232-1242
-
-
Ichinose, K.1
Maeshima, Y.2
Yamamoto, Y.3
Kinomura, M.4
Hirokoshi, K.5
Kitayama, H.6
Takazawa, Y.7
Sugiyama, H.8
Yamasaki, Y.9
Agata, N.10
Makino, H.11
-
18
-
-
4344593893
-
Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: Effects of an ACE inhibitor and an angiotensin II receptor antagonist
-
Kakizawa H, Itoh Y, Imamura S, Matsumoto T, Ishiwata Y, Ono Y, Yamamoto K, Kato T, Hayakawa N, Oda N, Goto Y, Nagasaka A, Senda T, Itoh M. Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: effects of an ACE inhibitor and an angiotensin II receptor antagonist. Horm Metab Res 36: 458-464, 2004.
-
(2004)
Horm Metab Res
, vol.36
, pp. 458-464
-
-
Kakizawa, H.1
Itoh, Y.2
Imamura, S.3
Matsumoto, T.4
Ishiwata, Y.5
Ono, Y.6
Yamamoto, K.7
Kato, T.8
Hayakawa, N.9
Oda, N.10
Goto, Y.11
Nagasaka, A.12
Senda, T.13
Itoh, M.14
-
19
-
-
0034917262
-
Impaired angiogenesis in the remnant kidney model. II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function
-
Kang DH, Hughes J, Mazzali M, Schreiner GF, Johnson RJ. Impaired angiogenesis in the remnant kidney model. II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 12: 1448-1457, 2001.
-
(2001)
J Am Soc Nephrol
, vol.12
, pp. 1448-1457
-
-
Kang, D.H.1
Hughes, J.2
Mazzali, M.3
Schreiner, G.F.4
Johnson, R.J.5
-
20
-
-
0034922841
-
Impaired angiogenesis in the remnant kidney model. I. Potential role of vascular endothelial growth factor and thrombospondin-1
-
Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, Gordon KL, Mazzali M, Jefferson JA, Hughes J, Madsen KM, Schreiner GF, Johnson RJ. Impaired angiogenesis in the remnant kidney model. I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 12: 1434-1447, 2001.
-
(2001)
J Am Soc Nephrol
, vol.12
, pp. 1434-1447
-
-
Kang, D.H.1
Joly, A.H.2
Oh, S.W.3
Hugo, C.4
Kerjaschki, D.5
Gordon, K.L.6
Mazzali, M.7
Jefferson, J.A.8
Hughes, J.9
Madsen, K.M.10
Schreiner, G.F.11
Johnson, R.J.12
-
21
-
-
0033667542
-
Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy
-
Kim YG, Suga SI, Kang DH, Jefferson JA, Mazzali M, Gordon KL, Matsui K, Breiteneder-Geleff S, Shankland SJ, Hughes J, Kerjaschki D, Schreiner GF, Johnson RJ. Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int 58: 2390-2399, 2000.
-
(2000)
Kidney Int
, vol.58
, pp. 2390-2399
-
-
Kim, Y.G.1
Suga, S.I.2
Kang, D.H.3
Jefferson, J.A.4
Mazzali, M.5
Gordon, K.L.6
Matsui, K.7
Breiteneder-Geleff, S.8
Shankland, S.J.9
Hughes, J.10
Kerjaschki, D.11
Schreiner, G.F.12
Johnson, R.J.13
-
22
-
-
65349142464
-
Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice
-
Kosugi T, Heinig M, Nakayama T, Connor T, Yuzawa Y, Li Q, Hauswirth WW, Grant MB, Croker BP, Campbell-Thompson M, Zhang L, Atkinson MA, Segal MS, Nakagawa T. Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice. Am J Pathol 174: 1221-1229, 2009.
-
(2009)
Am J Pathol
, vol.174
, pp. 1221-1229
-
-
Kosugi, T.1
Heinig, M.2
Nakayama, T.3
Connor, T.4
Yuzawa, Y.5
Li, Q.6
Hauswirth, W.W.7
Grant, M.B.8
Croker, B.P.9
Campbell-Thompson, M.10
Zhang, L.11
Atkinson, M.A.12
Segal, M.S.13
Nakagawa, T.14
-
23
-
-
34547940686
-
Midkine is involved in tubulointerstitial in-flammation associated with diabetic nephropathy
-
Kosugi T, Yuzawa Y, Sato W, Arata-Kawai H, Suzuki N, Kato N, Matsuo S, Kadomatsu K. Midkine is involved in tubulointerstitial in-flammation associated with diabetic nephropathy. Lab Invest 87: 903-913, 2007.
-
(2007)
Lab Invest
, vol.87
, pp. 903-913
-
-
Kosugi, T.1
Yuzawa, Y.2
Sato, W.3
Arata-Kawai, H.4
Suzuki, N.5
Kato, N.6
Matsuo, S.7
Kadomatsu, K.8
-
24
-
-
58149343883
-
Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice
-
Ku CH, White KE, Dei Cas A, Hayward A, Webster Z, Bilous R, Marshall S, Viberti G, Gnudi L. Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice. Diabetes 57: 2824-2833, 2008.
-
(2008)
Diabetes
, vol.57
, pp. 2824-2833
-
-
Ku, C.H.1
White, K.E.2
Dei Cas, A.3
Hayward, A.4
Webster, Z.5
Bilous, R.6
Marshall, S.7
Viberti, G.8
Gnudi, L.9
-
25
-
-
10744227199
-
Circulating angiogenic factors and the risk of preeclampsia
-
Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350: 672-683, 2004.
-
(2004)
N Engl J Med
, vol.350
, pp. 672-683
-
-
Levine, R.J.1
Maynard, S.E.2
Qian, C.3
Lim, K.H.4
England, L.J.5
Yu, K.F.6
Schisterman, E.F.7
Thadhani, R.8
Sachs, B.P.9
Epstein, F.H.10
Sibai, B.M.11
Sukhatme, V.P.12
Karumanchi, S.A.13
-
26
-
-
54849175900
-
Downregulation of p22phox in retinal pigment epithelial cells inhibits choroidal neovascularization in mice
-
Li Q, Dinculescu A, Shan Z, Miller R, Pang J, Lewin AS, Raizada MK, Hauswirth WW. Downregulation of p22phox in retinal pigment epithelial cells inhibits choroidal neovascularization in mice. Mol Ther 16: 1688-1694, 2008.
-
(2008)
Mol Ther
, vol.16
, pp. 1688-1694
-
-
Li, Q.1
Dinculescu, A.2
Shan, Z.3
Miller, R.4
Pang, J.5
Lewin, A.S.6
Raizada, M.K.7
Hauswirth, W.W.8
-
27
-
-
54549125880
-
Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential
-
Li Q, Miller R, Han PY, Pang J, Dinculescu A, Chiodo V, Hauswirth WW. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential. Mol Vis 14: 1760-1769, 2008.
-
(2008)
Mol Vis
, vol.14
, pp. 1760-1769
-
-
Li, Q.1
Miller, R.2
Han, P.Y.3
Pang, J.4
Dinculescu, A.5
Chiodo, V.6
Hauswirth, W.W.7
-
28
-
-
34548851715
-
Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia
-
Li Z, Zhang Y, Ying Ma J, Kapoun AM, Shao Q, Kerr I, Lam A, O'Young G, Sannajust F, Stathis P, Schreiner G, Karumanchi SA, Protter AA, Pollitt NS. Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension 50: 686-692, 2007.
-
(2007)
Hypertension
, vol.50
, pp. 686-692
-
-
Li, Z.1
Zhang, Y.2
Ying Ma, J.3
Kapoun, A.M.4
Shao, Q.5
Kerr, I.6
Lam, A.7
O'Young, G.8
Sannajust, F.9
Stathis, P.10
Schreiner, G.11
Karumanchi, S.A.12
Protter, A.A.13
Pollitt, N.S.14
-
29
-
-
33745821648
-
Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth
-
Liang XB, Ma LJ, Naito T, Wang Y, Madaio M, Zent R, Pozzi A, Fogo AB. Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth. J Am Soc Nephrol 17: 1886-1895, 2006.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 1886-1895
-
-
Liang, X.B.1
Ma, L.J.2
Naito, T.3
Wang, Y.4
Madaio, M.5
Zent, R.6
Pozzi, A.7
Fogo, A.B.8
-
30
-
-
34249901258
-
Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy
-
Lindenmeyer MT, Kretzler M, Boucherot A, Berra S, Yasuda Y, Henger A, Eichinger F, Gaiser S, Schmid H, Rastaldi MP, Schrier RW, Schlondorff D, Cohen CD. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol 18: 1765-1776, 2007.
-
(2007)
J Am Soc Nephrol
, vol.18
, pp. 1765-1776
-
-
Lindenmeyer, M.T.1
Kretzler, M.2
Boucherot, A.3
Berra, S.4
Yasuda, Y.5
Henger, A.6
Eichinger, F.7
Gaiser, S.8
Schmid, H.9
Rastaldi, M.P.10
Schrier, R.W.11
Schlondorff, D.12
Cohen, C.D.13
-
31
-
-
34447625374
-
Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: An explanation for the paradoxical effects of VEGF in renal disease
-
Nakagawa T. Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease. Am J Physiol Renal Physiol 292: F1665-F1672, 2007.
-
(2007)
Am J Physiol Renal Physiol
, vol.292
-
-
Nakagawa, T.1
-
32
-
-
33846701668
-
Diabetic eNOS knockout mice develop advanced diabetic nephropathy
-
Nakagawa T, Sato W, Glushakova O, Heinig M, Clarke T, Campbell-Thompson M, Yuzawa Y, Atkinson M, Johnson RJ, Croker B. Diabetic eNOS knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol 18: 539-550, 2007.
-
(2007)
J Am Soc Nephrol
, vol.18
, pp. 539-550
-
-
Nakagawa, T.1
Sato, W.2
Glushakova, O.3
Heinig, M.4
Clarke, T.5
Campbell-Thompson, M.6
Yuzawa, Y.7
Atkinson, M.8
Johnson, R.J.9
Croker, B.10
-
33
-
-
0027408091
-
The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes
-
Nyengaard JR, Rasch R. The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes. Diabetologia 36: 189-194, 1993.
-
(1993)
Diabetologia
, vol.36
, pp. 189-194
-
-
Nyengaard, J.R.1
Rasch, R.2
-
34
-
-
58149478117
-
Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization
-
Pechan P, Rubin H, Lukason M, Ardinger J, Dufresne E, Hauswirth WW, Wadsworth SC, Scaria A. Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization. Gene Ther 16: 10-16, 2009.
-
(2009)
Gene Ther
, vol.16
, pp. 10-16
-
-
Pechan, P.1
Rubin, H.2
Lukason, M.3
Ardinger, J.4
Dufresne, E.5
Hauswirth, W.W.6
Wadsworth, S.C.7
Scaria, A.8
-
35
-
-
61649095399
-
Highefficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors
-
Petrs-Silva H, Dinculescu A, Li Q, Min SH, Chiodo V, Pang JJ, Zhong L, Zolotukhin S, Srivastava A, Lewin AS, Hauswirth WW. Highefficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. Mol Ther 17: 463-471, 2009.
-
(2009)
Mol Ther
, vol.17
, pp. 463-471
-
-
Petrs-Silva, H.1
Dinculescu, A.2
Li, Q.3
Min, S.H.4
Chiodo, V.5
Pang, J.J.6
Zhong, L.7
Zolotukhin, S.8
Srivastava, A.9
Lewin, A.S.10
Hauswirth, W.W.11
-
36
-
-
0028298178
-
Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin)
-
Pichler R, Giachelli CM, Lombardi D, Pippin J, Gordon K, Alpers CE, Schwartz SM, Johnson RJ. Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin). Am J Pathol 144: 915-926, 1994.
-
(1994)
Am J Pathol
, vol.144
, pp. 915-926
-
-
Pichler, R.1
Giachelli, C.M.2
Lombardi, D.3
Pippin, J.4
Gordon, K.5
Alpers, C.E.6
Schwartz, S.M.7
Johnson, R.J.8
-
38
-
-
0037631361
-
Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria
-
Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, Kalluri R. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 278: 12605-12608, 2003.
-
(2003)
J Biol Chem
, vol.278
, pp. 12605-12608
-
-
Sugimoto, H.1
Hamano, Y.2
Charytan, D.3
Cosgrove, D.4
Kieran, M.5
Sudhakar, A.6
Kalluri, R.7
-
39
-
-
33750713086
-
Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice
-
Sung SH, Ziyadeh FN, Wang A, Pyagay PE, Kanwar YS, Chen S. Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J Am Soc Nephrol 17: 3093-3104, 2006.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 3093-3104
-
-
Sung, S.H.1
Ziyadeh, F.N.2
Wang, A.3
Pyagay, P.E.4
Kanwar, Y.S.5
Chen, S.6
-
40
-
-
12344309059
-
Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells
-
Villegas G, Lange-Sperandio B, Tufro A. Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells. Kidney Int 67: 449-457, 2005.
-
(2005)
Kidney Int
, vol.67
, pp. 449-457
-
-
Villegas, G.1
Lange-Sperandio, B.2
Tufro, A.3
-
41
-
-
0034608948
-
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice
-
Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 97: 8015-8020, 2000.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 8015-8020
-
-
Ziyadeh, F.N.1
Hoffman, B.B.2
Han, D.C.3
Iglesias-De La Cruz, M.C.4
Hong, S.W.5
Isono, M.6
Chen, S.7
McGowan, T.A.8
Sharma, K.9
|